Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)9.26
  • Today's Change0.08 / 0.87%
  • Shares traded13.99k
  • 1 Year change+19.95%
  • Beta1.6221
Data delayed at least 15 minutes, as of Nov 25 2024 20:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year Bavarian Nordic A/S grew revenues 124.14% from 3.15bn to 7.06bn while net income improved from a loss of 347.38m to a gain of 1.48bn.
Gross margin52.38%
Net profit margin18.43%
Operating margin18.83%
Return on assets8.18%
Return on equity11.17%
Return on investment10.46%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.